Article Versions Notes

Li Z, Zhang H, Zheng W, Yan Z, Yang J, Li S, Huang W. Esaxerenone Protects against Diabetic Cardiomyopathy via Inhibition of the Chemokine and PI3K-Akt Signaling Pathway. Biomedicines. 2023; 11(12):3319. https://doi.org/10.3390/biomedicines11123319

Li, Ziyue, Huihui Zhang, Weihan Zheng, Zi Yan, Jiaxin Yang, Shiyu Li, and Wenhua Huang. 2023. "Esaxerenone Protects against Diabetic Cardiomyopathy via Inhibition of the Chemokine and PI3K-Akt Signaling Pathway" Biomedicines 11, no. 12: 3319. https://doi.org/10.3390/biomedicines11123319

Li, Z., Zhang, H., Zheng, W., Yan, Z., Yang, J., Li, S., & Huang, W. (2023). Esaxerenone Protects against Diabetic Cardiomyopathy via Inhibition of the Chemokine and PI3K-Akt Signaling Pathway. Biomedicines, 11(12), 3319. https://doi.org/10.3390/biomedicines11123319